Vice President Global Medical Affairs, Obesity Projects & Pipeline

Are you passionate about advancing medical science and leading strategic initiatives in the field of obesity? Do you possess the vision and expertise to drive late-stage project development and foster cross-functional collaboration along the development value chain? We are looking for a Vice President of Obesity in our Global Medical Affairs organization, and to join our innovative team at Novo Nordisk. If you are ready to play a crucial role in shaping the scientific direction of our obesity portfolio and make a meaningful impact on patient lives globally, read more and apply today for a life-changing career.

The job

As our Vice President (VP) for Global Medical Affairs (GMA), Obesity you will be responsible for the development, execution and communication of the Global Medical Affairs operational and scientific strategy for the late-stage compounds of our Obesity portfolio (phases 2, 3, and 4 , including RWE). You will be a leader of leaders to ensure successful end-to-end business processes with a strong focus on execution, communication, compliance and collaboration across the business and portfolio.

Reporting into the Corporate Vice President (CVP) of Global Medical Affairs (GMA) Obesity, MASH & ECH you will lead a team of at least 4 direct reports and up to 20 indirect referrals. You will represent GMA in Novo Nordisk Global Governance Boards with direct responsibility for the scientific project strategy.

This role is based in DK.

The main responsibilities of the role are:

• Lead the management and organisation of the GMA Obesity team: proactive lead according to Novo Nordisk Way, operating in alignment with the Obesity Therapeutic Area and Medical Affairs Strategy Direction. You will be responsible for ensuring cross-functional collaboration and synergies across Areas, including Commercial, Medical Affairs or Clinical Drug Development, as well as accountable for business decisions in compliance with international regulations and standards (EFPIA).
• Define strategies and set direction for process/processes: amongst others, you will be responsible for developing, executing and delivering the Global Medical Affairs operational, scientific and communication strategy for the Obesity portfolio aligned with Company Strategy, including project and portfolio strategy within focused countries and including Key Opinion Leaders and Health Care Professional strategies, the execution of a publication strategy and plan, or the development of Product Development Plans for late-stage projects, clinical trial execution and communications.
• Leadership: manage, motivate, train and develop a team of positive and engaged leaders in a culture of well-being. Capable of building strong relations with stakeholders within and beyond the organisation to enable execution of strategies and influence scientist, commercial and top management colleagues.

Qualifications

To ensure success in this role, you are expected to show a proven track record of the following functional and leadership skills:

• MD, PhD or DMSci degree in a relevant discipline, preferably with speciality in Endocrinology and/or special interest and research experience in Obesity.
• 5+ years of clinical experience managing as senior registrar and/or chief consultant, as well as extensive academic experience in direct research and administrative activities.
• 5+ years of managerial experience in the pharmaceutical industry, overseeing junior faculty members or trainees in obesity or metabolism-related areas.
• Experience in conducting clinical trials for obesity/metabolism drugs in development
• Independent record of publications in high impact journals.
• Excellent communication and presentation skills, as well as an understanding of global and local procedures and approaches.
• Interest, training and understanding in advanced clinical communication from clinical and/or basic research in obesity or metabolic diseases related areas.
• International experience will be valued.
• Fluent in English, both written and spoken.

About the department

Global Medical Affairs, Obesity, is part of our Global Medical Affairs department within our Product & Portfolio Strategy Executive Function. At large, Medical Affairs employs around 400 highly skilled colleagued spread across locations and focusing across Therapeutical Areas. Medical Affairs is involved across the development and commercialisation parts of our value chain, focusing on generating value by leading the scientific exchange between patients, expert communities, payers and the industry at large. The key pillars of Medical Affairs are driving insight-based decisions, strengthening evidence generation, leading scientific dialogue, guiding the best-in-class clinical care, and securing a future fit worldwide organisation.

Deadline

May 8, 2025

Working at Novo Nordisk

At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. 

At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.